4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-17-038521
Chief Executive Officer sold 3,000 shares at $50.02 ($150,060)
- Chief Executive Officer acquired 3,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schenkein David P Chief Executive Officer | 2017-06-06 | Option exercise | +1,100 | $0.30 | $333 | 1,100 | D |
| Schenkein David P Chief Executive Officer | 2017-06-06 | Sale | −1,100 | $50.02 | $55,022 | 0 | D |
| Schenkein David P Chief Executive Officer | 2017-06-07 | Option exercise | +1,900 | $0.30 | $575 | 1,900 | D |
| Schenkein David P Chief Executive Officer | 2017-06-07 | Sale | −1,900 | $50.02 | $95,038 | 0 | D |
| Derivatives | |||||||
| Schenkein David P Chief Executive Officer | 2017-06-06 | Option exercise · Stock option (right to buy) | −1,100 | 191,556 | D | ||
| Schenkein David P Chief Executive Officer | 2017-06-07 | Option exercise · Stock option (right to buy) | −1,900 | 189,656 | D | ||
| Open-market sales · 3,000 sh · avg $50.02 · $150,060 | |||||||
Loading xslF345X03/doc4.xml…